Airgas and Biologics Modular have made a three-year sales and service agreement. It is to provide modular research suites for life sciences and pharmaceutical customers.
Airgas and Biologics Modular, have jointly announced a three-year marketing, sales, and service agreement to provide modular facilities to serve as self-contained bio-repositories, bio-manufacturing sites, and research suites for health service providers, educational facilities, and pharmaceutical manufacturers.
Airgas will provide the specialty gases and equipment, cryogenic liquids and freezers, and laboratory design services while Biologics Modular will manufacture, fit out, and deliver the modular suites and provide site preparation.
“Many of our customers recognise the need to expand their life science assets but may have budget or facility constraint issues,” said Todd Morris, Airgas vice-president - university and laboratory markets.
“The Biologics Modular platform enables us to provide a flexible, cost-effective solution. Self-contained modular suites fully outfitted with the necessary equipment and gases or cryogenics serve as a viable short-term, and in some cases, permanent, solution.”
“Partnering with a company of the caliber of Airgas allows us to expand our sales and marketing to a larger channel of research, laboratory and pharmaceutical manufacturers,” said Clark H. Byrum, Jr., President and CEO of Biologics Modular. “Their experience with leading research institutions and life science companies, coupled with our innovative facilities platform, provides access to a broader array of solutions for our customers. We look forward to working with Airgas and their life science team in delivering a combined facility solution to our customers.”north